RSF1 intronic transcript 2

The term "RSF1 intronic transcript 2 (RSF1-IT2)" refers to a putative or annotation-specific non-coding RNA transcribed from an intronic region of the RSF1 gene locus[1]. No evidence indicates that this transcript encodes a protein, functions as a receptor or enzyme, or constitutes a drug target. Its biological and disease relevance is unreported; it may represent a speculative or unverified gene annotation. This designation may be a misnomer, missing standard nomenclature, or a variant not registered in major genomic resources[1][2]. Context: - The RSF1 gene encodes a chromatin remodeling factor ("Remodeling and spacing factor 1"), also known as "Hepatitis B X-antigen associated protein" (HBXAP), implicated in transcriptional regulation and chemoresistance mechanisms in cancers[2]. This protein, however, is different from any non-coding "RSF1 intronic transcript 2". - No recognized biological or pharmaceutical literature links "RSF1-IT2" to any receptor, classical gene target, or actionable disease association. Summary: RSF1 intronic transcript 2 does not refer to a canonical therapeutic target. It is more likely an incompletely characterized, potentially mislabelled, or non-standard non-coding transcript annotation associated with the RSF1 locus, without established functional or clinical significance.